Richard J. Epstein

4.5k total citations
129 papers, 3.3k citations indexed

About

Richard J. Epstein is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Richard J. Epstein has authored 129 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 48 papers in Molecular Biology and 31 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Richard J. Epstein's work include HER2/EGFR in Cancer Research (23 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Breast Cancer Treatment Studies (12 papers). Richard J. Epstein is often cited by papers focused on HER2/EGFR in Cancer Research (23 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Breast Cancer Treatment Studies (12 papers). Richard J. Epstein collaborates with scholars based in Hong Kong, China and Australia. Richard J. Epstein's co-authors include Thomas Yau, Ehrhardt Aa, John Money, Xiaomei Ouyang, I. W. F. Hanham, Brian Druker, Pierre Chan, Ronnie T.P. Poon, Paul J. Smith and Guo Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Richard J. Epstein

127 papers receiving 3.3k citations

Peers

Countries citing papers authored by Richard J. Epstein

Since Specialization

Citations

This map shows the geographic impact of Richard J. Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Epstein more than expected).

Fields of papers citing papers by Richard J. Epstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Epstein. The network helps show where Richard J. Epstein may publish in the future.

Co-authorship network of co-authors of Richard J. Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Epstein. A scholar is included among the top collaborators of Richard J. Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Epstein. Richard J. Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and validation of a deep learning model for improving detection of nonmelanoma skin cancers treated with Mohs micrographic surgery 2023 ·JAAD International ·Eugene Tan, (unknown), (unknown), Richard J. Epstein, David Lim, Frank Lin	10
2	The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor 2021 ·Tumor Biology ·Richard J. Epstein	9
3	Effective conservative management of locally advanced conjunctival melanoma using initial systemic therapy 2019 ·Clinical and Experimental Ophthalmology ·(unknown), Richard J. Epstein, Svetlana Cherepanoff, Robert M. Conway	1
4	Thyroid cancer in a patient with Lynch syndrome – case report and literature review 2017 ·Therapeutics and Clinical Risk Management ·(unknown), Andrew Parker, Allan D. Spigelman, Rodney J. Scott, Richard J. Epstein, (unknown), Katherine Samaras	7
5	Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer 2011 ·Medical Oncology ·HM Wong, Stanley C. K. Lau, Roland Leung, Joanne Chiu, (unknown), T Wong, Raymond Liang, Richard J. Epstein, Thomas Yau	16
6	Programmed Genetic Instability: A Tumor-Permissive Mechanism for Maintaining the Evolvability of Higher Species through Methylation-Dependent Mutation of DNA Repair Genes in the Male Germ Line 2008 ·Molecular Biology and Evolution ·Yang Zhao, Richard J. Epstein	15
7	Complications of traditional Chinese/herbal medicines (TCM)—a guide for perplexed oncologists and other cancer caregivers 2008 ·Supportive Care in Cancer ·Joanne Chiu, Thomas Yau, Richard J. Epstein	32
8	Clinicopathological correlates in a cohort of Hong Kong breast cancer patients presenting with screen-detected or symptomatic disease. 2007 ·PubMed ·(unknown), Joyce Wing Yan Mak, Polly S. Y. Cheung, Richard J. Epstein	6
9	Acute presentation of rheumatoid arthritis following cancer chemotherapy using the topoisomerase I inhibitor irinotecan 2005 ·Acta Oncologica ·Thomas Yau, Kin Wah Chu, Mo Yin Mok, Raymond Liang, Richard J. Epstein	2
10	Treatment with HER-2 phosphorylation agonists enhance tumor ability to stimulate epitope specific CTL in vitro 2002 ·Oncology Reports ·(unknown), Nancy E. Ward, Richard J. Epstein, Andrzej P. Kudelka, David M. Gershenson, Clay L. Efferson, Catherine A. O’Brian, Constantin G. Ioannides	3
11	Multisite phosphotyping of the ErbB-2 oncoprotein in human breast cancer. 2001 ·PubMed ·(unknown), (unknown), Guofu Huang, Catherine Harper‐Wynne, (unknown), Richard J. Epstein	10
12	Astigmatism Management 2000 ·International Ophthalmology Clinics ·Tal Raviv, Richard J. Epstein	11
13	Overexpression of ErbB2 impairs ligand-dependent downregulation of epidermal growth factor receptors via a post-transcriptional mechanism 1999 ·Journal of Cellular Biochemistry ·(unknown), Andrew Chantry, Richard J. Epstein	26
14	Bad genes, bad diseases, and bad luck 1998 ·QJM ·Richard J. Epstein	1
15	Human Cancer Cells Exhibit Protein Kinase C-dependent c-erbB-2 Transmodulation That Correlates with Phosphatase Sensitivity and Kinase Activity 1996 ·Journal of Biological Chemistry ·Xiaomei Ouyang, T. Gulliford, Hongyi Zhang, Guo Huang, Richard J. Epstein	22
16	Active minimisation of radiation scatter during breast radiotherapy: management implications for young patients with good-prognosis primary neoplasms 1996 ·Radiotherapy and Oncology ·Richard J. Epstein, Steve Kelly, Michael B. Cook, (unknown), Ian Paddick, (unknown), P. Dunn, I. W. F. Hanham, R.G. Dale, Pat Price	21
17	Preferential detection of catalytically inactive c-erbB-2 by antibodies to unphosphorylated peptides mimicking receptor tyrosine autophosphorylation sites. 1995 ·PubMed ·Richard J. Epstein	13
18	Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor. 1992 ·Proceedings of the National Academy of Sciences ·Richard J. Epstein, Brian Druker, Thomas M. Roberts, Charles D. Stiles	52
19	Modulation of a Mr 175,000 c-neu receptor isoform in G8/DHFR cells by serum starvation. 1990 ·Journal of Biological Chemistry ·Richard J. Epstein, Brian Druker, Thomas M. Roberts, Charles D. Stiles	29
20	Mitogen-induced topoisomerase II synthesis precedes DNA synthesis in human breast cancer cells 1989 ·Biochemical and Biophysical Research Communications ·Richard J. Epstein, Paul J. Smith	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact